NDC 67979-002 – Supprelin La

Histrelin Acetate 50 mg/1 · Implant · Subcutaneous

Human Prescription Drug

Product NDC67979-002

Product details

Brand name
Supprelin La
Generic name
Histrelin acetate
Labeler
Endo USA, Inc.
Dosage form
Implant
Route
Subcutaneous
Marketing category
NDA · NDA022058
Marketed since
May 31, 2007
Listing expires
December 31, 2026
Pharmacologic class
Gonadotropin Releasing Hormone Receptor Agonist

Active ingredients

Uses, dosage, side effects and warnings for Supprelin →

Package NDC codes (1)

Package NDCDescriptionSince
67979-002-011 VIAL, GLASS in 1 CARTON (67979-002-01) / 1 IMPLANT in 1 VIAL, GLASSMay 31, 2007